Skystar Bio Pharmaceutical Company (NasdaqCM:SKBI) is seeking acquisitions. Skystar Bio Pharmaceutical is planning to raise $5 million from registered direct offering and plans to use part of proceeds for acquisitions too. Skystar Bio Pharmaceutical said, "The Company shall use a portion of the proceeds of the offering for acquisitions, licenses of new vaccine and aquaculture products, research & development and other general corporate purposes."